Therapeutical category:

Oral broad-spectrum cephalosporin

Characteristics:

Granules obtained by means of dry compaction of the crystalline powder without adding any excipients. No solvents are used in the process for higher purity and improved odour of the product, with the exception of acetone used for the final product wash.

Applications:

The product is suitable for the manufacture of capsules after the addition of appropriate excipients.

Regulatory information:

USA: FDA

EU: EDQM

Canada: HC

Bangladesh: MoH

China: CFDA

Taiwan: DoH

India: MoH

South Korea: KFDA